Cargando…
Challenges and perspectives of Chagas disease: a review
Chagas disease (CD), also known as American trypanosomiasis, is caused by the flagellated protozoan Trypanosoma cruzi, and affects an estimated 8 to 10 million people worldwide. In Latin America, 25 million people live in risk areas, while in 2008 alone, 10,000 CD-related deaths were reported. This...
Autores principales: | Pereira, Paulo Câmara Marques, Navarro, Elaine Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898031/ https://www.ncbi.nlm.nih.gov/pubmed/24354455 http://dx.doi.org/10.1186/1678-9199-19-34 |
Ejemplares similares
-
Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
por: Mansoldo, Felipe Raposo Passos, et al.
Publicado: (2020) -
Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013) -
Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020) -
The translational challenge in Chagas disease drug development
por: Kratz, Jadel M, et al.
Publicado: (2022) -
Translational challenges of animal models in Chagas disease drug development: a review
por: Chatelain, Eric, et al.
Publicado: (2015)